TORONTO, February 16, 2022 — Skylight Health Group Inc. (NASDAQ: SLHG: SLHGP; TSXV: SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, announced that its Board of Directors has authorized, and the Company has declared, a dividend on its 9.25% Series A Cumulative Redeemable Perpetual Preferred Shares (the “Series A Preferred Shares”) for the month of March 2022. The Series A Preferred Shares trade under the “SLHGP” stock ticker symbol.
In accordance with the terms of the Series A Preferred Shares, the Series A dividend will be payable in cash in the amount of $0.1927 per share on March 21, 2022 to the shareholders of record of the Series A Preferred Stock as of the dividend record date of February 28, 2022.
The Company is also announcing the issuance of 317,759 shares related to its previously announced acquisition of River City Medical Associates announced on February 4, 2021. All issued shares will be subject to a four-month hold from the date of issuance and is subject to TSX-V approval.